Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder
Coping After Loss Through Mindfulness Training in Grieving Adults With Prolonged Grief Disorder - A Neuroimaging Pilot Study
University Hospital, Caen
30 participants
Aug 1, 2023
INTERVENTIONAL
Summary
The goal of this clinical trial is to pilot the effectiveness of an 8-week standardized Mindfulness Training program to decrease the psychiatric and somatic symptoms of prolonged grief disorder (PGD) and to examine changes in physiological and neuroimaging biomarkers of bereavement-related stress reactivity that are associated with Mindfulness Training in grieving adult patients (men and women, aged 18-60) who are diagnosed with PGD. The main questions it aims to answer are: 1. What is the effectiveness of Mindfulness Training to lower PGD symptom severity? 2. What is the effectiveness of Mindfulness Training on physiological and neuroimaging biomarkers of stress reactivity? 3. What are the potential mechanisms of treatment change of Mindfulness Training? Participants will be: * randomly assigned to immediately receiving an 8-week Mindfulness Training program or after a 12-week waitlist. * assessed for psychiatric and somatic symptoms and for physiological responses during a baseline, midpoint and endpoint visit, and at a one-month follow-up visit. * assessed for functional neuroimaging biomarkers of bereavement-related and general stress reactivity at the baseline and endpoint visits using a script-driven imagery task (which induces bereavement-related stress reactivity during an imagery of a personal situation related to the death compared to imagery of a neutral personal situation), and loud tones stress task (which induces general stress reactivity). Researchers will compare the Mindfulness Training group (which consists of patients with PGD who will receive the Mindfulness Training immediately) with the waitlist control group (which consists of patients with PGD who are waiting on a waitlist to receive the training after the Mindfulness Training group) to investigate if they differ in PGD symptom severity as well as physiological and neuroimaging biomarkers of stress reactivity.
Eligibility
Inclusion Criteria3
- Must have lost a loved one (spouse, romantic partner, parent, child, sibling, close friend)
- Must have a score >29 on the Inventory of Complicated Grief (ICG)
- Clinical diagnosis of Prolonged Grief Disorder as assessed by the Structured Clinical Interview for Complicated Grief (SCI-CG)
Exclusion Criteria12
- History of a lifetime clinical diagnosis of schizophrenia
- History of a lifetime clinical diagnosis of bipolar disorder
- History of a lifetime clinical diagnosis of a psychotic disorder
- Current diagnosis of substance or alcohol use disorder within the past 12 months
- History of a neurologic disease, seizures, stroke or head injury resulting in prolonged loss of consciousness and/or neurological sequelae
- Current pregnancy as assessed by a urinary pregnancy test at screening during the Screening (week -4 until 0), Baseline (week 0) or Endpoint visit (week 8), or lack of use approved methods birth control for women of childbearing age
- Currently practice of mind-body techniques at least once a week (e.g., yoga) in the past 3 months
- Currently undergoing concomitant psychotherapy for grief (any psychotherapy)
- Left-handedness
- Current use of medications that would affect cerebral metabolism
- Any contraindications to Magnetic Resonance Imaging (MRI)
- Being under legal guardianship
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Meditation Training consists of 8 weekly sessions of Mindfulness Training and is adapted from the group-based Stress Management and Resiliency Training - Relaxation Response Resiliency Program, SMART-3RP. This training is structured around the following four goals: 1. Education about stress response 2. Elicitation of the Relaxation Response through Mindfulness Training 3. Creating adaptive perspectives 4. Coping strategiest.
The waitlist consists of a waiting time of 12 weeks during which participants will nog receive any type of intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06017765